Investing Profile

Vincent Brichard

Investor
Senior Vice-president at GlaxoSmithKline Biologicals
Brussels
Photo of Vincent Brichard, Investor
Your Intro Paths to Vincent Brichard

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Vincent Brichard on

cb
Current Investing Position
Investor
Investment Range
$1M - $5.0M
Sweet Spot
$1.5M
Investments On Record
5

Vincent Brichard is on these Sector & Stage Rankings

Vincent Brichard's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Minervax
Series UnknownOct 2023$57M
$140M
Co-investors: Veronica Gambillara Fonck (Pureos Bioventures), Kabeer Aziz (Adjuvant Capital), Christopher Gagliardi (Sanofi Ventures)
ImCheck Therapeutics
Series CJun 2022$100M
Series BDec 2019$53M
$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Raphael Wisniewski (Andera Partners), Michael Baran (Pfizer Venture Investments), Rémi Droller (Kurma Partners), Dr. Regina Hodits (Wellington Partners), Florent Gros (Earlybird Venture Capital)
Egle Therapeutics
Series AOct 2021$47M
$47M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Jacques Mizrahi (Bioqube Ventures)
FoRx Therapeutics
SeedApr 2020$11M
$11M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Therese Liechtenstein (M Ventures (Merck)), Vincent Ossipow (Omega Funds)

Vincent Brichard's Experience

Venture Partner EQT Life Sciences2016 - 2022